Overture Life
Pioneering Fertility Technology
Palo Alto, United States · $35.6M raised
- Headquarters
- Palo Alto, California
- Business Model
- B2B
- Total Funding
- $35.6M
- Last Round
- $15.0M Series BApr 2025
- Rounds
- 2
About
Overture Life is a clinical-stage biotechnology company that automates the most complex procedures in assisted reproductive technology, including IVF and embryology. Through its DaVitri platform and robotic fertilization systems, Overture automates egg and embryo vitrification and thawing to expand access to fertility care at lower cost, improve clinical outcomes, and let satellite clinics offer treatment closer to patients. The company achieved the world's first live births from robotic fertilization and holds a U.S. CLIA license for its Dallas-based IVF robotics clinical lab.
Summary
Overture Life is a Biotech company based in Palo Alto, United States. It has raised $35.6M in total across 2 rounds, most recently a $15.0M Series B round in Apr 2025. Investors include octopus investments, Overwater Ventures and GV.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
